Open access


Background: We investigated the traditional and new bio- markers as predictors of cardiovascular mortality in the func- tionally disabled elderly who are living in a community.

Methods: This prospective study included 253 participants (78.3% women) aged 65 and over who were monitored for 32 months. Receiver operating curve analysis and the Cox proportional hazard model were used to identify univariate and multivariate predictors of cardiovascular mortality. The Kaplan-Meier survival curve and Log rank test were used for survival analysis.

Results: During the study, 43.1% participants died from car- diovascular diseases. Cutoff points of multivariate predictors were used to build a score system. The risk score was positive in patients with three or more of the following predictors: albumin <40 g/L, body mass index <25 kg/m2, total serum bilirubin <10.5 (imol/L, blood urea nitrogen >6.5 mmol/L and high-sensitivity C-reactive protein >2.25 mg/L. The rel- ative risk for cardiovascular mortality for someone with a positive vs. negative score was 3.91 (95% Cl: 2.55-5.98; P< 0.001). There was no change in risk after adjustment for age; sex, traditional cardiovascular risk factors, comorbidities and a number of disabilities.

Conclusions: Presence of lo* grade inflammation, malnulri tion and early signs of renal dy sfunction are essential for car- diovascular risk among the functional disabled elderly and may be assessed using the proposed new inflammatory m3lnuhffion-renal involved score (1MRIS).

1. Institute of Public Health of Serbia. Ten most common causes of death by disease, sex and age groups in Republic of Serbia 2008. In: Kevi T, ed. Health Statistical Yearbook of Republic Serbia 2008, Institute of Public Health of Serbia, Belgrade 2009; p.49-50.

2. Auyeung TW, Lee JSW, Leung J, Kwok T, Leung PC, Woo J. Survival in older men may benefit from being slightly overweight and centrally obese: a 5-year follow-up study in 4,000 older adults using DXA. Gerontol A Biol Sci Med Sci 2010; 65 A(1): 99-104.

3. Cohen-Mansfield J, Perach R. Is there a reversal in the effect of obesity on mortality in old age? J Aging Res 2011; 765-71.

4. Vicher UM, Safar ME, Safar H, Iaria H, Dudal KL, Henry O, et al. Cardiometabolic determinants of mortality in a geriatric population: Is there a »reverse metabolic syndrome «? Diabetes & Metabolism 2009; 35: 108-14.

5. Molander L, Lovheim H, Norman T, Nordström P, Gus - tafson Y. Lower systolic blood pressure is associated with greater mortality in people aged 85 and older. J Am Geriatr Soc 2008; 56: 1853-9.

6. Weiss A, Beloosesky Y, Weiss HS, Grossman E, Boaz M. Serum total cholesterol: A mortality predictor in el derly hospitalized patients. Clin Nutr 2012 pii: S0261-5614(12)00258-0. doi: 10.1016/j.clnu.2012.11.012.

7. Weiss A, Boaz M, Beloosesky Y, Kornowski R, Grossman E. Body mass index and risk of all-cause and cardiovascular mortality in hospitalized elderly patients with diabetes mellitus. Diabet Med 2009; 26(3): 253-9.

8. Janssen I, Mark AE. Elevated body mass index and mortality risk in the elderly. Obes Rev 2007 Jan; 8(1): 41-59.

9. Heiat A. Impact of age on definition of standards for ideal weight. Prev Cardiol 2003; 6(2): 104-7.

10. Oreopoulos A, Kalantar-Zadeh K, Sharma AM, Fonarow GC. The obesity paradox in the elderly: Potential mechanisms and clinical implications. Clin Geriatr Med 2009; 25: 643-59.

11. Miller SL, Wolfe RR. The danger of weight loss in the elderly. J Nutr Health Aging 2008;12: 487-9.

12. Bonanni A, Mannucci I, Verzola D, Sofia A, Saffioti S, Gianetta E, Garibotto G. Protein-Energy Wasting and Mortality in Chronic Kidney Disease. Int J Environ Res Public Health 2011; 8(5): 1631-54.

13. Katz S, Down TD, Cash HR, et al. Progress in the deve l - opment of the index of ADL. Gerontologist 1970; 10: 20-30.

14. Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chau - veau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Trevinho-Becerra A, Wanner C. A Proposed Nomenclature and Diagnostic Criteria For Protein-Energy Wasting In Acute and Chronic Kidney Disease. Kidney Int 2008; 73(4): 391-8.

15. Filippatos GS, Desai RV, Ahmed MI, Fonarow GC, Love TE, Aban IB, Iskandrian AE, Konstam MA, Ahmed A. Hypoalbuminaemia and incident heart failure in older adults. Eur J Heart Fail 2011; 13(10): 1078-86.

16. Kinugasa Y, Kato M, Sugihara S, Hirai M, Kotani K, Ishida K, Yanagihara K, Kato Y, Ogino K, Igawa O, Hisa tome I, Shigemasa C. A Simple Risk Score to Predict In-Hospital Death of Elderly Patients With Acute De com pen sated Heart Failure. Hypoalbuminemia as an Addi tional Prog - nostic Factor. Circ J 2009; 73: 2276-81.

17. Gheorghiade M, Zannad F, Sopko G, Klein L, Piña IL, Konstam MA, Massie BM, Roland E, Targum S, Collins SP, Filippatos G, Tavazz L, for the International Working Group on Acute Heart Failure Syndromes. Special Report: Acute Heart Failure Syndromes, Current State and Framework for Future Research Circulation 2005; 112: 3958-68.

18. Peterson PN, Rumsfeld JS, Liang L, Albert NM, Her - nandez AF, Peterson ED, Fonarow GC, Masoudi FA. A Validated Risk Score for In-Hospital Mortality in Patients With Heart Failure From the American Heart Association Get With the Guidelines Program Circulation: Cardio - vascular Quality and Outcomes 2010; 3: 25-32.

19. Takahashi R, Ito Y, Takahashi H, Ishii H, Kasuga H, Mizuno M, Suzuki Y, Yuzawa Y, Maruyama S, Murohara T, Imai E, Matsuo S. Combined values of serum albumin, C-reactive protein and body mass index at dialysis ini - tiation accurately predicts long-term mortality. Am J Nephrol 2012; 36(2): 136-43.

20. Yao Q, Lindholm B, Stenvinkel P. Inflammation as a cause of malnutrition, atherosclerotic cardiovascular disease, and poor outcome in hemodialysis patients. Hemodial Int 2004; 8(2): 118-29.

21. Terrier N, Senécal L, Dupuy AM, Jaussent I, Delcourt C, Leray H, Rafaelsen S, Bosc JY, Maurice F, Canaud B, Cristol JP. Association between novel indices of malnutrition- inflammation complex syndrome and cardiovascular disease in hemodialysis patients. Hemodial Int 2005; 9(2): 159-68.

22. Akdag I, Yilmaz Y, Kahvecioglu S, Bolca N, Ercan I, Ersoy A, Gullulu M. Clinical value of the malnutrition-inflammation- atherosclerosis syndrome for long-term prediction of cardiovascular mortality in patients with end-stage renal disease: a 5-year prospective study. Nephron Clin Pract 2008; 108(2): c99-c105.

23. Dummer CD, Thome FS, Veronese FV. Chronic renal dis - ease, inflammation and atherosclerosis: new concepts about an old problem. Rev Assoc Med Bras 2007; 53(5): 446-50.

24. Clarke R, Emberson JR, Breeze E, Casas JP, Parish S, Hingorani AD, et al. Biomarkers of inflammation predict both vascular and non-vascular mortality in older men. European Heart Journal 2008; 29: 800-9.

25. Hwang HJ, Lee SW, Kim SH. Relationship between bilirubin and C-reactive protein. Clin Chem Lab Med 2011; 49(11): 1823-8.

26. Oda E, Kawai R. A possible cross-sectional association of serum total bilirubin with coronary heart disease and stroke in a Japanese health screening population. Heart Vessels 2012; 27(1): 29-36.

27. National Academy of Clinical Biochemistry. Emerging Biomarkers for Primary Prevention of Cardiovascular Disease and Stroke. Washington, DC: National Academy of Clinical Biochemistry; 2009.

28. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffee MW. Studies of illness in the aged: The Index of ADL, a standardized measure of biological and psychological function. JAMA 1963; 185: 914-19.

29. Lawton MP, Brody EM. Assessment of older people: Selfmaintaining and instrumental activities of daily living. The Gerontologist 1969; 9(3): 179-86.

30. Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method for classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.

31. Taylor JMG, Ankerst DP, Andridge RR. Validation of biomarker- based risk prediction models. Clin Cancer Res 2008; 14(19).

32. Grunkemeier GL, Jin R. Receiver operating characteristic curve analysis of clinical risk models. Ann Thorac Surg 2001; 72: 323-6.

33. Grunkemeier GL, Wu Y. Bootstrap resampling methods. something for nothing? Ann Thorac Surg 2004; 77: 1142-4.

34. IBM SPSS Bootstrapping 19. SPSS Inc. 1989, 2010.

35. Meng SJ and Yu LJ. Oxidative stress, molecular inflammation and sarcopenia. Int J Mol Sci 2010; 11(4): 1509-26.

36. Licastro F, Candore G, Lio D, Porcellini E, Colonna- Romano G, Franceschi C, Caruso C. Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing 2005; 2-8.

37. Jenny NS, Yanez ND, Psaty BM, Kuller LH, Hirsch CH, Tracy RP. Inflammation biomarkers and near-term death in older men. Am J Epidemiol 2007; 165: 684-95.

38. Koenig W, Khuseyinova N, Baumert J, Meisinger C. Proteomics and protein markers: prospective study of high-sensitivity C-reactive protein as a determinant of mortality: Results from the MONICA/KORA Augsburg Cohort Study, 1984-1998. Clin Chem 2008; 54: 335-42.

39. Korita I, Bulo A, Longlois M, Blaton V. Inflammation markers in patients with cardiovascular disease and metabolic syndrome. Journal of Medical Biochemistry 2013; 32: 214-9.

40. Pap D, ^olak E, Majki}-Singh N, Grabor-Laj{i} G, Vickovi} S. Lipoproteins and other risk factors for cardiovascular disease in a student population. Journal of Medical Biochemistry 2013; 32: 140-5.

41. Carriere I, Dupuy AM, Lacroux A, Cristol JP, Delcourt C, and the POLA Study Group. Biomarkers of inflammation and malnutrition associated with early death in healthy elderly people. J Am Geriatr Soc 2008; 56(5): 840-6.

42. Djoussé L, Rothman KJ, Cupples LA, Levy D, Ellison RC. Serum albumin and risk of myocardial infarction and allcause mortality in the Framingham Offspring Study. Circulation 2002; 106: 2919-24.

43. Gillum RF. Assessment of serum albumin concentration as a risk factor for stroke and coronary disease in African Americans and whites. J Natl Med Assoc 2000; 92: 3-9.

44. Bouillanne O, Dupont-Belmont C, Hay P, Hamon-Vilcot B, Cynober L, Aussel C. Fat mass protects hospitalized elderly persons against morbidity and mortality. Am J Clin Nutr 2009; 90: 505-10.

45. Widlansky ME, Sesso HD, Rexrode KM, Manson JE, Gaziano JM. Body mass index and total and cardiovascular mortality in men with a history of cardiovascular disease. Arch Intern Med 2004; 164: 2326-32.

46. Buettner HJ, Mueller C, Gick M, Ferenc M, Allgeier J, Comberg T, et al. The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction. Eur Heart J 2007; 28:1694-701.

47. Weiss A, Beloosesky Y, Boaz M, Yalov A, Kornowski R, Grossman E. Body mass index is inversely related to mortality in elderly subjects. J Gen Intern Med 2008; 23(1): 19-24.

48. Smith GL, Shlipak MG, Havranek EP, Foody JM, Masoudi FA, Rathore SS, Krumholz HM. Serum urea nitrogen, creatinine, and estimators of renal function. Mortality in older patients with cardiovascular disease. Arch Intern Med 2006; 166: 1134-42.

49. Kirtane AJ, Leder DM, Waikar SS, et al. for the TIMI Study Group. Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates. J Am Coll Cardiol 2005; 45: 1781-6.

50. Öllinger R, Bilban M, Erat A, Froio A., McDaid J, Tyagi S, et al. Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation. Circulation 2005; 112: 1030-9.

51. Novotny L, Vitek L. Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med 2003; 228: 568-71.

52. Lin JP, O’Donnell CJ, Schwaiger JP, Cupples LA, Lingen - hel A, Hunt SC, et al. Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. Circulation 2006; 114: 1476-81.

53. Perlstein TS, Pande RL, Beckman JA, Creager MA. Se - rum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. Arterio - scler Thromb Vasc Biol 2008; 28: 166-72.

54. Perlstein TS, Pande, RL, Creager MA, Weuve J, Beckman JA. Serum total bilirubin level, prevalent stroke, and stroke outcomes: National Health and Nutrition Exam - ination Survey. Am J Med 2008; 121(9): 781-8.

55. Kimm H, Yun JE, Jo J, Jee SH. Low serum bilirubin level as an independent predictor of stroke incidence. Stroke 2009; 40: 3422-7.

Journal of Medical Biochemistry

The Journal of Society of Medical Biochemists of Serbia

Journal Information

IMPACT FACTOR 2017: 1.378
5-year IMPACT FACTOR: 0.704

CiteScore 2018: 1.47

SCImago Journal Rank (SJR) 2018: 0.523
Source Normalized Impact per Paper (SNIP) 2018: 0.581

Cited By


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 138 102 10
PDF Downloads 68 57 3